These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12900367)

  • 1. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.
    Katz MH; Spivack DE; Takimoto S; Fang B; Burton DW; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2003 Aug; 10(7):762-72. PubMed ID: 12900367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
    Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells.
    Jacob D; Schumacher G; Bahra M; Davis J; Zhu HB; Zhang LD; Teraishi F; Neuhaus P; Fang BL
    World J Gastroenterol; 2005 May; 11(17):2552-6. PubMed ID: 15849810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter.
    Jacob D; Bahra M; Schumacher G; Neuhaus P; Fang B
    Anticancer Res; 2004; 24(5A):3075-9. PubMed ID: 15517918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenoviral vector expressing the TRAIL gene driven by the hTERT promoter].
    Jacob D; Davis J; Schumacher G; Bahra M; Neuhaus P; Fang B
    Z Gastroenterol; 2004 Dec; 42(12):1363-70. PubMed ID: 15592959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
    Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
    Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
    Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY
    Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.
    Jacob D; Davis JJ; Zhang L; Zhu H; Teraishi F; Fang B
    Cancer Gene Ther; 2005 Feb; 12(2):109-15. PubMed ID: 15486557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma.
    Chang JY; Zhang X; Komaki R; Cheung R; Fang B
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1482-94. PubMed ID: 16580499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.
    Lin T; Huang X; Gu J; Zhang L; Roth JA; Xiong M; Curley SA; Yu Y; Hunt KK; Fang B
    Oncogene; 2002 Nov; 21(52):8020-8. PubMed ID: 12439752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
    Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated gene transfer of caspase-8 sensitizes human adenocarcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand.
    Yasui H; Adachi M; Hamada H; Imai K
    Int J Oncol; 2005 Feb; 26(2):537-44. PubMed ID: 15645141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kazhdan I; Marciniak RA
    Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).
    Yang F; Shi P; Xi X; Yi S; Li H; Sun Q; Sun M
    Med Oncol; 2006; 23(2):191-204. PubMed ID: 16720919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.